Valuation: Valbiotis

Market Cap 19.4M 22.15M 17.87M 16.59M 31.49M 2.11B 31.92M 214M 83.24M 1.04B 83.18M 81.36M 3.6B P/E 2026 *
-2.63x
P/E 2027 * -10.3x
Enterprise Value 20.6M 23.52M 18.97M 17.61M 33.44M 2.24B 33.9M 227M 88.39M 1.1B 88.33M 86.39M 3.82B EV / Sales 2026 *
5.35x
EV / Sales 2027 * 1.31x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day-3.53%
1 week+2.50%
Current month+1.99%
1 month-18.00%
3 months-23.36%
6 months+18.84%
Current year+18.16%
1 week 0.77
Extreme 0.773
0.87
1 month 0.74
Extreme 0.735
0.97
Current year 0.65
Extreme 0.653
1.3
1 year 0.54
Extreme 0.535
1.3
3 years 0.54
Extreme 0.535
7.5
5 years 0.54
Extreme 0.535
7.5
10 years 0.54
Extreme 0.535
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/03/2024
Chief Tech/Sci/R&D Officer - 01/09/2017
Director TitleAgeSince
Chairman 55 01/03/2017
Director/Board Member - 26/10/2017
Director/Board Member - 18/03/2019
Date Insider Type Main position Quantity % Market Cap.
28/01/22Others

Founder

42,480 0.4364%
28/01/22Fiscal year

Founder

2,095 0.0215%
10/07/21Fiscal year

Chief Technology Officer

10,000 0.1030%
Change 5-day change 1-year change 3-year change Capi.($)
-3.53%+2.50%-4.87%-79.40% 23M
-2.14%+3.51%+74.05%+131.10% 59.1B
-0.93%-2.54%+73.64%+93.71% 55.19B
-3.71%-0.35%-14.61%-11.19% 24.67B
-0.05%+6.49%+14.05%+451.36% 24.19B
-1.38%+7.57%+48.58%-1.53% 19.69B
-2.19%+6.34%+40.74%-29.60% 17.56B
+3.58%+13.78%+196.41%+348.55% 16.22B
-0.96%+18.41%+46.57% - 14.84B
-0.57%+2.30%+20.33%+187.27% 14.04B
Average -1.24%+7.26%+49.49%+121.14% 24.55B
Weighted average by Cap. -1.26%+5.67%+58.06%+135.66%

Financials

2026 *2027 *
Net sales 3.85M 4.4M 3.55M 3.29M 6.25M 419M 6.34M 42.45M 16.52M 206M 16.51M 16.15M 714M 13.25M 15.13M 12.2M 11.33M 21.51M 1.44B 21.8M 146M 56.85M 708M 56.82M 55.57M 2.46B
Net income -8.75M -9.99M -8.06M -7.48M -14.21M -953M -14.4M -96.47M -37.54M -468M -37.52M -36.7M -1.62B -5.35M -6.11M -4.93M -4.57M -8.69M -583M -8.8M -58.99M -22.96M -286M -22.94M -22.44M -992M
Net Debt 1.2M 1.37M 1.11M 1.03M 1.95M 131M 1.97M 13.23M 5.15M 64.15M 5.15M 5.03M 222M -2.1M -2.4M -1.93M -1.8M -3.41M -229M -3.46M -23.15M -9.01M -112M -9M -8.81M -389M
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
06/07/26 EUR 0.8200 -3.53% 119,950
03/07/26 EUR 0.8500 +2.91% 258,287
02/07/26 EUR 0.8260 +4.56% 116,972
01/07/26 EUR 0.7900 -1.74% 152,943
30/06/26 EUR 0.8040 +0.50% 179,774
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8200EUR
Average target price
2.228EUR
Spread / Average Target
+171.66%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALVAL Stock